Found: 12
Select item for more details and to access through your institution.
Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation.
- Published in:
- Cell Transplantation, 2021, v. 30, p. 1, doi. 10.1177/09636897211001774
- By:
- Publication type:
- Article
Arguments against the Requirement of a Biological License Application for Human Pancreatic Islets: The Position Statement of the Islets for US Collaborative Presented during the FDA Advisory Committee Meeting.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2878, doi. 10.3390/jcm10132878
- By:
- Publication type:
- Article
Evaluating the Prognostic Value of Islet Autoantibody Monitoring in Islet Transplant Recipients with Long-Standing Type 1 Diabetes Mellitus.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 12, p. 2708, doi. 10.3390/jcm10122708
- By:
- Publication type:
- Article
Induction of a transient graft vs. leukemia effect following unrelated cord blood transplantation.
- Published in:
- Pediatric Transplantation, 2002, v. 6, n. 4, p. 348, doi. 10.1034/j.1399-3046.2002.00215.x
- By:
- Publication type:
- Article
Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta‐cell function after total pancreatectomy with islet autotransplantation – a prospective study.
- Published in:
- Transplant International, 2019, v. 32, n. 3, p. 280, doi. 10.1111/tri.13364
- By:
- Publication type:
- Article
Pain resolution and glucose control in pediatric patients with chronic pancreatitis after total pancreatectomy with islet auto-transplantation.
- Published in:
- Pediatric Surgery International, 2021, v. 37, n. 10, p. 1383, doi. 10.1007/s00383-021-04956-5
- By:
- Publication type:
- Article
Evidence of non-pancreatic beta cell-dependent roles of Tcf7l2 in the regulation of glucose metabolism in mice.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 6, p. 1646, doi. 10.1093/hmg/ddu577
- By:
- Publication type:
- Article
Peri‐operative Reparixin therapy resulted in 50% 5‐year insulin independence rate: The University of Chicago experience.
- Published in:
- Clinical Transplantation, 2023, v. 37, n. 5, p. 1, doi. 10.1111/ctr.14981
- By:
- Publication type:
- Article
119-OR: Total Pancreatectomy with Islet Autotransplantation in Diabetic and Prediabetic Patients with Intractable Chronic Pancreatitis.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-119-OR
- By:
- Publication type:
- Article
222-OR: BETA-2 Calculated Based on Single Fasting Blood Sample Allows to Define and Discriminate between Optimal and Suboptimal Islet Allograft Function Prior to the Clinical Need for Insulin Support.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-222-OR
- By:
- Publication type:
- Article
220-OR: Is There Any Prognostic Value of Diabetes-Associated Autoantibody Levels for Predicting Islet Graft Function in Patients with Long-Standing Type 1 Diabetes Mellitus?
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-220-OR
- By:
- Publication type:
- Article
218-OR: Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment and Clinical Outcomes after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-218-OR
- By:
- Publication type:
- Article